The clinical antiprotozoal drug nitazoxanide and its metabolite tizoxanide extend Caenorhabditis elegans lifespan and healthspan.
Acta Pharm Sin B
; 14(7): 3266-3280, 2024 Jul.
Article
in En
| MEDLINE
| ID: mdl-39027239
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Acta Pharm Sin B
Year:
2024
Document type:
Article
Affiliation country:
China
Country of publication:
Países Bajos